CMS posts Sunshine Act registration details
On Feb. 7, CMS posted a notice that it will begin accepting registrations for Sunshine Act aggregate-spending reports from industry on Feb. 18. Agg-spend reporting obliges the life sciences industries and GPOs to report payments offered to physicians. Additional data elements will be accepted in May, and all data will be made public later this year. Details at http://content.govdelivery.com/accounts/USCMS/bulletins/a3f695?reqfrom=share.
Articles in this issue
The pharma rep profession will be immortal
Six factors driving new specialty pharmacies
Common misconceptions about the orphan drug designation
AbbVie enters Asian manufacturing with a $320-million site in Singapore
So you are 'in the cloud;' now what?
Network effect of industry-crowdsourced physician data
Make your CRM vendor a true partner to your sales team
New adverse-events reporting service speeds results to payers
Acquisitions realign UK logistics services, cold chain packaging
After a relatively flat year, 2014 could be big for pharma M&A
IMS Institute assesses social media for industry significance
University-based consortium will develop standards for biomarker-based diagnostics
Fourteen compounding pharmacies have already applied for DQSA registration with FDA
Tim Wentworth is new Express Scripts president
Cargo theft of pharmaceuticals continues to fall in the US
Recent Videos
Related Content
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024Article
In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
